Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
companies
Jobs

Locations

Needham, MA, USA · Needham Heights, Needham, MA, USA

industry

Biotechnology

Size

51-200 employees

Stage

IPO

founded in

1999

Candel ($CADL) is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored Phase 1 clinical trial in recurrent high-grade glioma (HGG). In addition, Candel’s ENLIGHTEN™ discovery platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. CAN-2409 is the lead product candidate from the adenovirus platform and is currently in ongoing clinical trials in non-small cell lung cancer (NSCLC) (Phase 2).

Something looks off?
Open jobs at Candel

On-site & Remote